GSK said Bellus’ experimental cough medicine could help treat millions of people with untreatable chronic coughs and had “significant sales potential” if approved.
GSK said Bellus’ experimental cough medicine could help treat millions of people with untreatable chronic coughs and had “significant sales potential” if approved.